Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Maas BM"'
Autor:
Maas BM; Merck & Co., Inc., Rahway, New Jersey, USA., Strizki J; Merck & Co., Inc., Rahway, New Jersey, USA., Miller RR; Merck & Co., Inc., Rahway, New Jersey, USA., Kumar S; Merck & Co., Inc., Rahway, New Jersey, USA., Brown M; Merck & Co., Inc., Rahway, New Jersey, USA., Johnson MG; Merck & Co., Inc., Rahway, New Jersey, USA., Cheng M; Merck & Co., Inc., Rahway, New Jersey, USA., De Anda C; Merck & Co., Inc., Rahway, New Jersey, USA., Rizk ML; Merck & Co., Inc., Rahway, New Jersey, USA., Stone JA; Merck & Co., Inc., Rahway, New Jersey, USA.
Publikováno v:
Clinical and translational science [Clin Transl Sci] 2024 Feb; Vol. 17 (2), pp. e13732.
Autor:
Phuah JY; Merck & Co., Inc., Rahway, NJ, USA., Maas BM; Merck & Co., Inc., Rahway, NJ, USA., Tang A; Merck & Co., Inc., Rahway, NJ, USA., Zhang Y; Merck & Co., Inc., Rahway, NJ, USA., Caro L; Merck & Co., Inc., Rahway, NJ, USA., Railkar RA; Merck & Co., Inc., Rahway, NJ, USA., Swanson MD; Merck & Co., Inc., Rahway, NJ, USA., Cao Y; Merck & Co., Inc., Rahway, NJ, USA., Li H; Merck & Co., Inc., Rahway, NJ, USA., Roadcap B; Merck & Co., Inc., Rahway, NJ, USA., Catchpole AP; hVivo Services Ltd, 42 New Road, London, UK., Aliprantis AO; Merck & Co., Inc., Rahway, NJ, USA., Vora KA; Merck & Co., Inc., Rahway, NJ, USA. Electronic address: kalpit.vora@merck.com.
Publikováno v:
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2023 Dec 31; Vol. 169, pp. 115851. Date of Electronic Publication: 2023 Nov 14.
Autor:
Bihorel S; Simulation Plus, Cognigen Division, Buffalo, New York, USA., Cao Y; Merck & Co., Inc., Rahway, New Jersey, USA., Chawla A; Merck & Co., Inc., Rahway, New Jersey, USA., Birger R; Merck & Co., Inc., Rahway, New Jersey, USA., Maas BM; Merck & Co., Inc., Rahway, New Jersey, USA., Gao W; Merck & Co., Inc., Rahway, New Jersey, USA., Roepcke S; Simulation Plus, Cognigen Division, Buffalo, New York, USA., Sardella S; Simulation Plus, Cognigen Division, Buffalo, New York, USA., Humphrey R; Simulation Plus, Cognigen Division, Buffalo, New York, USA., Kondragunta S; Simulation Plus, Cognigen Division, Buffalo, New York, USA., Jayaraman B; Simulation Plus, Cognigen Division, Buffalo, New York, USA., Martinho M; Merck & Co., Inc., Rahway, New Jersey, USA., Painter W; Ridgeback Biotherapeutics LP, Miami, Florida, USA., Painter G; Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, Georgia, USA., Holman W; Ridgeback Biotherapeutics LP, Miami, Florida, USA., De Anda C; Merck & Co., Inc., Rahway, New Jersey, USA., Brown ML; Merck & Co., Inc., Rahway, New Jersey, USA., Johnson MG; Merck & Co., Inc., Rahway, New Jersey, USA., Paschke A; Merck & Co., Inc., Rahway, New Jersey, USA., Rizk ML; Merck & Co., Inc., Rahway, New Jersey, USA., Stone JA; Merck & Co., Inc., Rahway, New Jersey, USA.
Publikováno v:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2023 Dec; Vol. 12 (12), pp. 1859-1871. Date of Electronic Publication: 2023 Oct 05.
Autor:
Iwamoto M; Merck & Co., Inc., Rahway, New Jersey, USA., Duncan KE; Merck & Co., Inc., Rahway, New Jersey, USA., Wickremasingha PK; Merck & Co., Inc., Rahway, New Jersey, USA., Zhao T; Merck & Co., Inc., Rahway, New Jersey, USA., Liberti MV; Merck & Co., Inc., Rahway, New Jersey, USA., Lemoine L; Merck & Co., Inc., Rahway, New Jersey, USA., Decaesteker T; Merck & Co., Inc., Rahway, New Jersey, USA., Rottey S; Ghent University Hospital, Ghent, Belgium., Maas BM; Merck & Co., Inc., Rahway, New Jersey, USA., Gillespie G; Merck & Co., Inc., Rahway, New Jersey, USA., Stoch SA; Merck & Co., Inc., Rahway, New Jersey, USA.
Publikováno v:
Clinical and translational science [Clin Transl Sci] 2023 Oct; Vol. 16 (10), pp. 1947-1956. Date of Electronic Publication: 2023 Aug 08.
Autor:
Chawla A; Merck & Co., Inc., Rahway, New Jersey, USA., Birger R; Merck & Co., Inc., Rahway, New Jersey, USA., Wan H; Merck & Co., Inc., Rahway, New Jersey, USA., Cao Y; Merck & Co., Inc., Rahway, New Jersey, USA., Maas BM; Merck & Co., Inc., Rahway, New Jersey, USA., Paschke A; Merck & Co., Inc., Rahway, New Jersey, USA., De Anda C; Merck & Co., Inc., Rahway, New Jersey, USA., Rizk ML; Merck & Co., Inc., Rahway, New Jersey, USA., Stone JA; Merck & Co., Inc., Rahway, New Jersey, USA.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2023 Jun; Vol. 113 (6), pp. 1337-1345. Date of Electronic Publication: 2023 Apr 27.
Autor:
Nakamura K; MSD K.K., Tokyo, Japan.; Oita University, Oita, Japan., Fujimoto K; MSD K.K., Tokyo, Japan., Hasegawa C; MSD K.K., Tokyo, Japan., Aoki I; MSD K.K., Tokyo, Japan., Yoshitsugu H; MSD K.K., Tokyo, Japan., Ugai H; MSD K.K., Tokyo, Japan., Yatsuzuka N; MSD K.K., Tokyo, Japan., Tanaka Y; MSD K.K., Tokyo, Japan., Furihata K; P-One Clinic, Keikokai Medical Corp., Tokyo, Japan., Maas BM; Merck & Co., Inc., Rahway, New Jersey, USA., Wickremasingha PK; Merck & Co., Inc., Rahway, New Jersey, USA., Duncan KE; Merck & Co., Inc., Rahway, New Jersey, USA., Iwamoto M; Merck & Co., Inc., Rahway, New Jersey, USA., Stoch SA; Merck & Co., Inc., Rahway, New Jersey, USA., Uemura N; Oita University, Oita, Japan.
Publikováno v:
Clinical and translational science [Clin Transl Sci] 2022 Nov; Vol. 15 (11), pp. 2697-2708. Date of Electronic Publication: 2022 Sep 23.
Autor:
Orito Y; MSD K.K., Tokyo, Japan., Otani N; Oita University, Oita, Japan., Matsumoto Y; MSD K.K., Tokyo, Japan., Fujimoto K; MSD K.K., Tokyo, Japan., Oshima N; MSD K.K., Tokyo, Japan., Maas BM; Merck and Co., Inc., Rahway, New Jersey, USA., Caro L; Merck and Co., Inc., Rahway, New Jersey, USA., Aliprantis AO; Merck and Co., Inc., Rahway, New Jersey, USA.; Flagship Pioneering, Boston, Massachusetts, USA., Cox KS; Merck and Co., Inc., Rahway, New Jersey, USA., Tokumaru O; Oita University, Oita, Japan., Kodama M; Oita University, Oita, Japan., Kudo H; Oita University, Oita, Japan., Imai H; Oita University, Oita, Japan., Uemura N; Oita University, Oita, Japan.
Publikováno v:
Clinical and translational science [Clin Transl Sci] 2022 Jul; Vol. 15 (7), pp. 1753-1763. Date of Electronic Publication: 2022 May 17.
Autor:
Maas BM; Merck & Co., Inc., 2000 Galloping Hill Rd, Kenilworth, NJ 07033, USA., Lommerse J; Certara, 100 Overlook Center STE 101, Princeton, NJ 08540, USA., Plock N; Certara, 100 Overlook Center STE 101, Princeton, NJ 08540, USA., Railkar RA; Merck & Co., Inc., 2000 Galloping Hill Rd, Kenilworth, NJ 07033, USA., Cheung SYA; Certara, 100 Overlook Center STE 101, Princeton, NJ 08540, USA., Caro L; Merck & Co., Inc., 2000 Galloping Hill Rd, Kenilworth, NJ 07033, USA., Chen J; Merck & Co., Inc., 2000 Galloping Hill Rd, Kenilworth, NJ 07033, USA., Liu W; Merck & Co., Inc., 2000 Galloping Hill Rd, Kenilworth, NJ 07033, USA., Zhang Y; Merck & Co., Inc., 2000 Galloping Hill Rd, Kenilworth, NJ 07033, USA., Huang Q; Merck & Co., Inc., 2000 Galloping Hill Rd, Kenilworth, NJ 07033, USA., Gao W; Merck & Co., Inc., 2000 Galloping Hill Rd, Kenilworth, NJ 07033, USA., Qin L; Certara, 100 Overlook Center STE 101, Princeton, NJ 08540, USA., Meng J; Certara, 100 Overlook Center STE 101, Princeton, NJ 08540, USA., Witjes H; Certara, 100 Overlook Center STE 101, Princeton, NJ 08540, USA., Schindler E; Certara, 100 Overlook Center STE 101, Princeton, NJ 08540, USA., Guiastrennec B; Certara, 100 Overlook Center STE 101, Princeton, NJ 08540, USA., Bellanti F; Certara, 100 Overlook Center STE 101, Princeton, NJ 08540, USA., Spellman DS; Merck & Co., Inc., 2000 Galloping Hill Rd, Kenilworth, NJ 07033, USA., Roadcap B; Merck & Co., Inc., 2000 Galloping Hill Rd, Kenilworth, NJ 07033, USA., Kalinova M; hVivo Services Ltd, 42 New Road, London E1 1JT, UK., Fok-Seang J; hVivo Services Ltd, 42 New Road, London E1 1JT, UK., Catchpole AP; hVivo Services Ltd, 42 New Road, London E1 1JT, UK., Espeseth AS; Merck & Co., Inc., 2000 Galloping Hill Rd, Kenilworth, NJ 07033, USA., Stoch SA; Merck & Co., Inc., 2000 Galloping Hill Rd, Kenilworth, NJ 07033, USA., Lai E; Merck & Co., Inc., 2000 Galloping Hill Rd, Kenilworth, NJ 07033, USA., Vora KA; Merck & Co., Inc., 2000 Galloping Hill Rd, Kenilworth, NJ 07033, USA., Aliprantis AO; Merck & Co., Inc., 2000 Galloping Hill Rd, Kenilworth, NJ 07033, USA., Sachs JR; Merck & Co., Inc., 2000 Galloping Hill Rd, Kenilworth, NJ 07033, USA. Electronic address: jeff_sachs@merck.com.
Publikováno v:
EBioMedicine [EBioMedicine] 2021 Nov; Vol. 73, pp. 103651. Date of Electronic Publication: 2021 Nov 11.
Autor:
Aliprantis AO; Merck & Co., Inc., Kenilworth, New Jersey, USA., Wolford D; Merck & Co., Inc., Kenilworth, New Jersey, USA., Caro L; Merck & Co., Inc., Kenilworth, New Jersey, USA., Maas BM; Merck & Co., Inc., Kenilworth, New Jersey, USA., Ma H; Merck & Co., Inc., Kenilworth, New Jersey, USA., Montgomery DL; Merck & Co., Inc., Kenilworth, New Jersey, USA., Sterling LM; Celerion, Lincoln, Nebraska, USA., Hunt A; Celerion, Lincoln, Nebraska, USA., Cox KS; Merck & Co., Inc., Kenilworth, New Jersey, USA., Vora KA; Merck & Co., Inc., Kenilworth, New Jersey, USA., Roadcap BA; Merck & Co., Inc., Kenilworth, New Jersey, USA., Railkar RA; Merck & Co., Inc., Kenilworth, New Jersey, USA., Lee AW; Merck & Co., Inc., Kenilworth, New Jersey, USA., Stoch SA; Merck & Co., Inc., Kenilworth, New Jersey, USA., Lai E; Merck & Co., Inc., Kenilworth, New Jersey, USA.
Publikováno v:
Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2021 May; Vol. 10 (5), pp. 556-566. Date of Electronic Publication: 2020 Oct 30.
Autor:
Dumond JB; UNC Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Greene SA; Present address: SK Life Science, Inc., Fairlawn, NJ, USA., Prince HMA; UNC School of Medicine, Department of Internal Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Chen J; Present address: Merck CO, Philadelphia, PA, USA., Maas BM; Present address: Merck CO, Philadelphia, PA, USA., Sykes C; UNC Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Schauer AP; UNC Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Blake KH; UNC Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Nelson JAE; UNC School of Medicine, Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Gay CL; UNC School of Medicine, Department of Internal Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Kashuba ADM; UNC Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; UNC School of Medicine, Department of Internal Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Cohen MS; UNC School of Medicine, Department of Internal Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Publikováno v:
Antiviral therapy [Antivir Ther] 2019; Vol. 24 (1), pp. 45-50.